Highbridge Capital Management’s Aimei Health Technology Right AFJKR Stock Holding History
Bought
Maintained
Sold
Other funds holding AFJKR
Highbridge Capital Management's AFJKR Position: Q3 2026 in Review
Highbridge Capital Management sold out of Aimei Health Technology Right (AFJKR) in Q3 2026, closing a stake of 871,784 shares — an estimated $296K sold.
Highbridge Capital Management first reported a position in AFJKR in Q1 2024 and held it in 10 quarters. The position peaked at $360K in Q4 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q3 2026.
- Highbridge Capital Management reported no remaining Aimei Health Technology Right position as of Q3 2026 after selling out during the quarter.
- Highbridge Capital Management sold 871,784 Aimei Health Technology Right shares in Q3 2026, an estimated $296K.
- Highbridge Capital Management first reported a position in Aimei Health Technology Right in Q1 2024 and held it in 10 quarters.
- Highbridge Capital Management's Aimei Health Technology Right position peaked at $360K in Q4 2025.
- 15 funds tracked by Wall St. Rank held Aimei Health Technology Right as of Q3 2026.
Based on Highbridge Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.